PetMed Express, Inc.



$42.69Share Price
$872 MMarket Cap
5.7%EBIT / EV
4.4%FCF / EV
96.0%Cash ROIC
2.3%3yr Avg Revenue Growth
4.91Current Ratio
star logo

Business Model Diligence

We do not yet have Business Model Diligence for this stock.

Statistical Diligence

check mark The EBIT / Enterprise Value of 5.7% ranks as Average.
check mark The Free Cash Flow / Enterprise Value of 4.4% ranks as Average.
check mark The Return on Invested Capital Value of 123.8% ranks as Very High.
check mark The Cash Return on Capital Value of 96.0% ranks as Very High.
check mark The 3 Year Average Revenue Growth Value of 2.3% ranks as Average.
check mark Near-term Financial Health appears to be Very Good. The Current Ratio is 4.91.

Company Description

PetMed Express, Inc. engages in the provision of markets prescription and non-prescription pet medications, health products and supplies for dogs and cats. Its non-prescription medications include flea and tick control products, bone and joint care products, vitamins and nutritional supplements, and hygiene products; and it also offers prescription medications include heartworm preventatives, arthritis, thyroid, diabetes and pain medications, antibiotics and other specialty medications, as well as generic substitutes. The firm markets its products through national television, online and direct mail/print advertising campaigns. The company's products include a majority of brands of medication such as Frontline Plus, K9 Advantix II, Advantage II, Heartgard Plus, Sentinel, Revolution and Rimadyl. Petmed Express was founded in January 1996 and is headquartered in Pompano Beach, FL.


You must have a MagicDiligence Membership to view the Calculations for this stock. If you are already a member, you need to log in first.